Cargando…
Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis
OBJECTIVE: Epstein–Barr virus (EBV) is a well-recognized oncogenic virus that can induce host cell metabolic reprogramming and tumorigenesis by targeting vital metabolic enzymes or regulators. This study aims to explore the role of wild-type isocitrate dehydrogenase 2 (IDH2) in metabolic reprogrammi...
Autores principales: | Shi, Feng, He, Ya, Li, Jiangjiang, Tang, Min, Li, Yueshuo, Xie, Longlong, Zhao, Lin, Hu, Jianmin, Luo, Xiangjian, Zhou, Min, Liu, Na, Fan, Jia, Zhou, Jian, Gao, Qiang, Qiu, ShuangJian, Wu, Weizhong, Zhang, Xin, Jia, Weihua, Bode, Ann M., Cao, Ya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109632/ https://www.ncbi.nlm.nih.gov/pubmed/32224436 http://dx.doi.org/10.1016/j.molmet.2020.02.009 |
Ejemplares similares
-
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy
por: Hu, Jianmin, et al.
Publicado: (2020) -
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum
por: Hu, Jianmin, et al.
Publicado: (2022) -
Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer
por: Li, Jiangjiang, et al.
Publicado: (2018) -
Targeting the signaling in Epstein–Barr virus-associated diseases: mechanism, regulation, and clinical study
por: Cao, Ya, et al.
Publicado: (2021) -
EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter
por: Shi, Feng, et al.
Publicado: (2019)